AVITA Medical Submits FDA PMA Supplement for RECELL GO
VALENCIA, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of…
Browsing Tag
AVITA Medical
AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo…
VALENCIA, Calif. and MELBOURNE, Australia, June 16, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and…
AVITA Medical Announces Update to Automation Device
<!-- Name:DistributionId Value:8807797 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
AVITA Medical Appoints New Non-Executive Member to the Board of Directors
<!-- Name:DistributionId Value:8790117 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
AVITA Medical Submits FDA PMA Application to Expand Indication to Vitiligo
VALENCIA, Calif., and MELBOURNE, Australia, Dec. 19, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and…
AVITA Medical® to Host Investor Webinar Briefing
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and…
AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of…
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and…
AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 03, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and…
Investor Webinar Briefing
VALENCIA, Calif. and MELBOURNE, Australia, Sept. 13, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and…
RECELL® System Data to be Presented at the Controversies and Conversations in Laser…
VALENCIA, Calif. and MELBOURNE, Australia, Aug. 17, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and…